Barinthus Biotherapeutics (BRNS) Cash from Investing Activities (QoQ) (2020 - 2026)
Barinthus Biotherapeutics (BRNS) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,650.00% |
| Dec 31, 2025 | -99.56% |
| Sep 30, 2025 | 1,509.38% |
| Jun 30, 2025 | -540.00% |
| Mar 31, 2025 | 98.20% |
| Dec 31, 2024 | -143.86% |
| Sep 30, 2024 | 40.63% |
| Jun 30, 2024 | 37.66% |
| Mar 31, 2024 | -301.31% |
| Dec 31, 2023 | 525.00% |
| Sep 30, 2023 | 98.81% |
| Jun 30, 2023 | -20.58% |
| Mar 31, 2023 | -327.82% |
| Dec 31, 2022 | 70.96% |
| Sep 30, 2022 | 1.75% |
| Jun 30, 2022 | -88.10% |
| Mar 31, 2022 | 91.04% |
| Dec 31, 2021 | -9,423.44% |
| Sep 30, 2021 | 36.63% |
| Jun 30, 2021 | 48.47% |